{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,26]],"date-time":"2025-05-26T20:10:10Z","timestamp":1748290210044,"version":"3.41.0"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,5,26]]},"DOI":"10.7759\/cureus.84852","type":"journal-article","created":{"date-parts":[[2025,5,26]],"date-time":"2025-05-26T19:36:44Z","timestamp":1748288204000},"source":"Crossref","is-referenced-by-count":0,"title":["Molecular Docking and In Silico Predictive Analysis of Potential Herb-Drug Interactions Between Momordica charantia and Miglitol"],"prefix":"10.7759","author":[{"given":"Ponnusankar","family":"S","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Preethi","family":"R","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lithish","family":"Kumar MK","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vishal Kesav","family":"TR","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harshini","family":"VS","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rajesh Kumar","family":"R","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Balasubramaniam","family":"V","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","unstructured":"Diabetes. (2025). Accessed. February 19, 2025: https:\/\/www.who.int\/health-topics\/diabetes."},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1111\/1753-0407.13576","article-title":"The rising prevalence of type 2 diabetes among the youth in southern India-An ancillary analysis of the Secular TRends in DiabEtes in India (STRiDE-I) study","volume":"16","author":"Nanditha A","year":"2024","unstructured":"Nanditha A, Susairaj P, Satheesh K, Raghavan A, Snehalatha C, Ramachandran A. The rising prevalence of type 2 diabetes among the youth in southern India-An ancillary analysis of the Secular TRends in DiabEtes in India (STRiDE-I) study. J Diabetes. 2024, 16:e13576. 10.1111\/1753-0407.13576","journal-title":"J Diabetes"},{"key":"ref3","unstructured":"Miglitol - an overview | ScienceDirect Topics. (2025). Accessed.  February 19, 2025: https:\/\/www.sciencedirect.com\/topics\/chemistry\/miglitol."},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1345\/aph.19269","article-title":"Miglitol: assessment of its role in the treatment of patients with diabetes mellitus","volume":"34","author":"Campbell LK","year":"2000","unstructured":"Campbell LK, Baker DE, Campbell RK. Miglitol: assessment of its role in the treatment of patients with diabetes mellitus. Ann Pharmacother. 2000, 34:1291-1301. 10.1345\/aph.19269","journal-title":"Ann Pharmacother"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-200059030-00012","article-title":"Miglitol: a review of its therapeutic potential in type 2 diabetes mellitus","volume":"59","author":"Scott LJ","year":"2000","unstructured":"Scott LJ, Spencer CM. Miglitol: a review of its therapeutic potential in type 2 diabetes mellitus. Drugs. 2000, 59:521-549. 10.2165\/00003495-200059030-00012","journal-title":"Drugs"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1272\/jnms.JNMS.2021_88-205","article-title":"Efficacy and safety of miglitol- or repaglinide-based combination therapy with alogliptin for drug-na\u00efve patients with type 2 diabetes: an open-label, single-center, parallel, randomized controlled pilot study","volume":"88","author":"Okajima F","year":"2021","unstructured":"Okajima F, Sugihara H, Emoto N. Efficacy and safety of miglitol- or repaglinide-based combination therapy with alogliptin for drug-na\u00efve patients with type 2 diabetes: an open-label, single-center, parallel, randomized controlled pilot study. J Nippon Med Sch. 2021, 88:71-79. 10.1272\/jnms.JNMS.2021_88-205","journal-title":"J Nippon Med Sch"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1002\/cpdd.1268","article-title":"Bioequivalence study of miglitol orally disintegrating tablets in healthy Chinese volunteers under fasting condition based on pharmacodynamic and pharmacokinetic parameters","volume":"12","author":"Zhao MX","year":"2023","unstructured":"Zhao MX, Wu JL, Dong LC, et al.. Bioequivalence study of miglitol orally disintegrating tablets in healthy Chinese volunteers under fasting condition based on pharmacodynamic and pharmacokinetic parameters. Clin Pharmacol Drug Dev. 2023, 12:1089-1098. 10.1002\/cpdd.1268","journal-title":"Clin Pharmacol Drug Dev"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1002\/cpdd.873","article-title":"Bioequivalence and evaluation parameters based on the pharmacodynamics of miglitol in healthy volunteers","volume":"10","author":"Yan J","year":"2021","unstructured":"Yan J, Li XM, Zhang YX, et al.. Bioequivalence and evaluation parameters based on the pharmacodynamics of miglitol in healthy volunteers. Clin Pharmacol Drug Dev. 2021, 10:582-587. 10.1002\/cpdd.873","journal-title":"Clin Pharmacol Drug Dev"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1186\/s12906-024-04385-6","article-title":"Views of healthcare professionals on complementary and alternative medicine use by patients with diabetes: a qualitative study","volume":"24","author":"Alzahrani AS","year":"2024","unstructured":"Alzahrani AS, Greenfield SM, Shrestha S, Paudyal V. Views of healthcare professionals on complementary and alternative medicine use by patients with diabetes: a qualitative study. BMC Complement Med Ther. 2024, 24:81. 10.1186\/s12906-024-04385-6","journal-title":"BMC Complement Med Ther"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1186\/1749-8546-4-11","article-title":"Hypoglycemic herbs and their action mechanisms","volume":"4","author":"Hui H","year":"2009","unstructured":"Hui H, Tang G, Go VL. Hypoglycemic herbs and their action mechanisms. Chin Med. 2009, 4:11. 10.1186\/1749-8546-4-11","journal-title":"Chin Med"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.3390\/molecules27072175","article-title":"Bioactives of Momordica charantia as potential anti-diabetic\/hypoglycemic agents","volume":"27","author":"Xu B","year":"2022","unstructured":"Xu B, Li Z, Zeng T, Zhan J, Wang S, Ho CT, Li S. Bioactives of Momordica charantia as potential anti-diabetic\/hypoglycemic agents. Molecules. 2022, 27:2175. 10.3390\/molecules27072175","journal-title":"Molecules"},{"key":"ref12","unstructured":"Herb Drug Interaction - an overview | ScienceDirect Topics. (2025). Accessed. March 17, 2025: https:\/\/www.sciencedirect.com\/topics\/immunology-and-microbiology\/herb-drug-interaction."},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1301\/nr.2006.jul.331-337","article-title":"Bitter gourd (Momordica Charantia): a dietary approach to hyperglycemia","volume":"64","author":"Krawinkel MB","year":"2006","unstructured":"Krawinkel MB, Keding GB. Bitter gourd (Momordica Charantia): a dietary approach to hyperglycemia. Nutr Rev. 2006, 64:331-337. 10.1301\/nr.2006.jul.331-337","journal-title":"Nutr Rev"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24097870","article-title":"Optimization of magnetic and paper-based molecularly imprinted polymers for selective extraction of charantin in Momordica charantia","volume":"24","author":"Nuchtavorn N","year":"2023","unstructured":"Nuchtavorn N, Leanpolchareanchai J, Visansirikul S, Bunsupa S. Optimization of magnetic and paper-based molecularly imprinted polymers for selective extraction of charantin in Momordica charantia. Int J Mol Sci. 2023, 24:7870. 10.3390\/ijms24097870","journal-title":"Int J Mol Sci"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24054643","article-title":"The effects of Momordica charantia on type 2 diabetes mellitus and Alzheimer's disease","volume":"24","author":"Richter E","year":"2023","unstructured":"Richter E, Geetha T, Burnett D, Broderick TL, Babu JR. The effects of Momordica charantia on type 2 diabetes mellitus and Alzheimer's disease. Int J Mol Sci. 2023, 24:4643. 10.3390\/ijms24054643","journal-title":"Int J Mol Sci"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1017\/S0007114509992054","article-title":"Anti-diabetic and hypoglycaemic effects of Momordica charantia (bitter melon): a mini review","volume":"102","author":"Leung L","year":"2009","unstructured":"Leung L, Birtwhistle R, Kotecha J, Hannah S, Cuthbertson S. Anti-diabetic and hypoglycaemic effects of Momordica charantia (bitter melon): a mini review. Br J Nutr. 2009, 102:1703-1708. 10.1017\/S0007114509992054","journal-title":"Br J Nutr"},{"key":"ref17","unstructured":"Herb-Drug Interactions | NCCIH. (2025). Accessed. March 17, 2025: https:\/\/www.nccih.nih.gov\/health\/providers\/digest\/herb-drug-interactions."},{"key":"ref18","unstructured":"PubChem. Charantin. (2025). Accessed: March 4, 2025: https:\/\/pubchem.ncbi.nlm.nih.gov\/."},{"key":"ref19","unstructured":"IMPPAT | IMPPAT. Indian Medicinal Plants, Phytochemistry and Therapeutics. (2025). Accessed: February 21, 2025: https:\/\/cb.imsc.res.in\/imppat\/."},{"key":"ref20","unstructured":"SwissADME. (2025). Accessed. February 21, 2025: http:\/\/www.swissadme.ch\/."},{"key":"ref21","article-title":"In vitro and in vivo study of inhibitory potentials of \u03b1-glucosidase and acetylcholinesterase and biochemical profiling of M. charantia in alloxan-induced diabetic rat models","volume":"14","author":"Hussain F","year":"2022","unstructured":"Hussain F, Hafeez J, Khalifa AS, Naeem M, Ali T, Eed EM. In vitro and in vivo study of inhibitory potentials of \u03b1-glucosidase and acetylcholinesterase and biochemical profiling of M. charantia in alloxan-induced diabetic rat models. Am J Transl Res. 2022, 14:3824-3839.","journal-title":"Am J Transl Res"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1007\/s13659-020-00241-5","article-title":"Cucurbitane-type triterpene glycosides from Momordica charantia and their \u03b1-glucosidase inhibitory activities","volume":"10","author":"Gao Y","year":"2020","unstructured":"Gao Y, Chen JC, Peng XR, Li ZR, Su HG, Qiu MH. Cucurbitane-type triterpene glycosides from Momordica charantia and their \u03b1-glucosidase inhibitory activities. Nat Prod Bioprospect. 2020, 10:153-161. 10.1007\/s13659-020-00241-5","journal-title":"Nat Prod Bioprospect"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.14670\/HH-26.13","article-title":"Effects of Momordica charantia on pancreatic histopathological changes associated with streptozotocin-induced diabetes in neonatal rats","volume":"26","author":"Abdollahi M","year":"2011","unstructured":"Abdollahi M, Zuki AB, Goh YM, Rezaeizadeh A, Noordin MM. Effects of Momordica charantia on pancreatic histopathological changes associated with streptozotocin-induced diabetes in neonatal rats. Histol Histopathol. 2011, 26:13-21. 10.14670\/HH-26.13","journal-title":"Histol Histopathol"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.3390\/foods9040434","article-title":"Exploring antioxidant and enzymes (A-Amylase and B-Glucosidase) inhibitory activity of Morinda lucida and Momordica charantia leaves from Benin","volume":"9","author":"Chokki M","year":"2020","unstructured":"Chokki M, Cud\u0103lbeanu M, Zongo C, et al.. Exploring antioxidant and enzymes (A-Amylase and B-Glucosidase) inhibitory activity of Morinda lucida and Momordica charantia leaves from Benin. Foods. 2020, 9:434. 10.3390\/foods9040434","journal-title":"Foods"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/356560-molecular-docking-and-in-silico-predictive-analysis-of-potential-herb-drug-interactions-between-momordica-charantia-and-miglitol","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,26]],"date-time":"2025-05-26T19:36:46Z","timestamp":1748288206000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/356560-molecular-docking-and-in-silico-predictive-analysis-of-potential-herb-drug-interactions-between-momordica-charantia-and-miglitol"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,26]]},"references-count":24,"URL":"https:\/\/doi.org\/10.7759\/cureus.84852","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5,26]]}}}